Wang, H., Hou, W., Perera, A., Bettler, C., Beach, J. R., Ding, X., . . . Qiu, W. (2021). Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling. Cell Rep.
استشهاد بنمط شيكاغوWang, Hao, et al. "Targeting EphA2 Suppresses Hepatocellular Carcinoma Initiation and Progression By Dual Inhibition of JAK1/STAT3 and AKT Signaling." Cell Rep 2021.
MLA استشهادWang, Hao, et al. "Targeting EphA2 Suppresses Hepatocellular Carcinoma Initiation and Progression By Dual Inhibition of JAK1/STAT3 and AKT Signaling." Cell Rep 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.